CORS&P 500

Cencora SEC filings, summarized

We read every Cencora 8-K filing and insider trade the night it hits SEC EDGAR, and turn it into a two-minute plain-English summary.

Track COR in your inbox

Add Cencora to your watchlist — free, every morning.

Subscribe free

Recent filings

Form 4 · Insider TradeAugust 25, 2026

Cencora EVP Elizabeth Campbell sells $3.66M in stock

Cencora Executive Vice President Elizabeth S. Campbell sold 11,300.471 shares of common stock in an open-market transaction at $324.12 per share, worth…

8-KAugust 14, 2026

Cencora director Lorence Kim resigns after joining Commonwealth Fusion Systems

Lorence H. Kim resigned from Cencora’s Board effective August 13, 2026, following his appointment as chief financial officer of Commonwealth Fusion Systems,…

8-KAugust 12, 2026

Cencora reaffirms fiscal 2026 adjusted EPS guidance

Cencora said certain Walgreens volume serviced outside its prime vendor agreement began moving away from the company on July 1, 2026; the prime vendor…

8-KAugust 5, 2026

Cencora raises fiscal 2026 EPS outlook after quarterly revenue and profit growth

Cencora reported fiscal third-quarter revenue of $84.8 billion for the period ended June 30, 2026, up 5.1% year over year, while GAAP diluted EPS rose to…

8-KAugust 5, 2026

Cencora raises fiscal 2026 EPS guidance after revenue and earnings growth

Cencora reported fiscal third-quarter revenue of $84.8 billion for the period ended June 30, 2026, up 5.1% year over year, while GAAP diluted EPS rose to…

8-KAugust 5, 2026

Cencora reports creation of a direct financial obligation

Cencora’s Aug. 5, 2026, 8-K states that it created a direct financial obligation or an obligation under an off-balance-sheet arrangement. The filing…

8-KAugust 5, 2026

Cencora Expands Revolving Credit Facility to $7 Billion Through 2031

Cencora and subsidiary Innomar Strategies amended their multi-currency senior unsecured revolving credit facility with JPMorgan Chase Bank as administrative…

8-KMarch 23, 2026

Cencora filed Form 8‑K (Item 9.01) on Mar 23, 2026 — furnished Exhibit 99.1 (press release dated Mar 23,…

Cencora filed Form 8‑K (Item 9.01) on Mar 23, 2026 — furnished Exhibit 99.1 (press release dated Mar 23, 2026). Investors should review the PR for material…

8-KMarch 23, 2026

Cencora ($COR) signed a definitive agreement (Mar 21, 2026; announced Mar 23, 2026) to acquire EyeSouth…

Cencora ($COR) signed a definitive agreement (Mar 21, 2026; announced Mar 23, 2026) to acquire EyeSouth Partners’ retina business. Press release furnished…

8-KMarch 17, 2026

Cencora filed a Form 8‑K on Mar 17, 2026 — Exhibits: 99.1 (Press Release) and 104 (Inline XBRL cover page).

Cencora filed a Form 8‑K on Mar 17, 2026 — Exhibits: 99.1 (Press Release) and 104 (Inline XBRL cover page). Filing signed by Elizabeth S. Campbell, EVP &…

8-KMarch 17, 2026

Cencora ($COR) on Mar 17, 2026 announced the retirement of Mr.

Cencora ($COR) on Mar 17, 2026 announced the retirement of Mr. Cleary and reaffirmed its previously issued adjusted diluted EPS guidance range for FY2026.…

8-KMarch 17, 2026

Cencora ($COR) announced on Mar 17, 2026 that James F.

Cencora ($COR) announced on Mar 17, 2026 that James F. Cleary will retire as Executive VP & CFO effective June 30, 2026. His retirement was not due to any…

8-KMarch 6, 2026

Cencora held its 2026 Annual Meeting on Mar 5, 2026.

Cencora held its 2026 Annual Meeting on Mar 5, 2026. All 11 director nominees were elected; "For" votes ranged ~163.3M–168.5M. Broker non‑votes: 9,738,568.…

8-KFebruary 13, 2026

Cencora ($COR) filed an 8‑K (Item 9.01) adding five supplemental indentures w/ U.S.

Cencora ($COR) filed an 8‑K (Item 9.01) adding five supplemental indentures w/ U.S. Bank Trust Co. for new senior notes: 3.95% due 2029, 4.25% due 2030,…

8-KFebruary 13, 2026

Filed 2/13/2026: Morgan, Lewis & Bockius LLP delivered a legal opinion on the validity of Cencora’s Notes…

Filed 2/13/2026: Morgan, Lewis & Bockius LLP delivered a legal opinion on the validity of Cencora’s Notes (attached as Exhibit 5.1) and consented to its…

8-KFebruary 13, 2026

Cencora ($COR) reports it closed the offering of its Notes, per Form 8‑K (Item 7.01).

Cencora ($COR) reports it closed the offering of its Notes, per Form 8‑K (Item 7.01). News release dated Feb 13, 2026 furnished as Exhibit 99.1. 📣 #Cencora…

8-KFebruary 13, 2026

Cencora ($COR) 8‑K filed 2026‑02‑13: Item 2.03 states that Item 1.01’s disclosures re: indentures and…

Cencora ($COR) 8‑K filed 2026‑02‑13: Item 2.03 states that Item 1.01’s disclosures re: indentures and notes are incorporated by reference as the creation of…

8-KFebruary 13, 2026

BREAKING: Cencora completes $3.0B sale of senior notes across five tranches (2029,2030,2033,2036,2056)…

BREAKING: Cencora completes $3.0B sale of senior notes across five tranches (2029,2030,2033,2036,2056) 🚨💵 Confirmed — $COR issued $3.0B of unsecured,…

8-KFebruary 11, 2026

Cencora filed an Underwriting Agreement dated Feb 10, 2026 with underwriters led by Citigroup, J.P.

Cencora filed an Underwriting Agreement dated Feb 10, 2026 with underwriters led by Citigroup, J.P. Morgan, BofA Securities & Wells Fargo (additional…

8-KFebruary 11, 2026

Cencora ($COR) entered an Underwriting Agreement on Feb 10, 2026 with Citigroup, J.P.

Cencora ($COR) entered an Underwriting Agreement on Feb 10, 2026 with Citigroup, J.P. Morgan, BofA & Wells Fargo to sell senior unsecured notes; expected…